tiprankstipranks
Eagle Pharmaceuticals Inc (EGRX)
OTHER OTC:EGRX
US Market

Eagle Pharmaceuticals (EGRX) Income Statement

Compare
210 Followers

Eagle Pharmaceuticals Income Statement

Last quarter (Q2 2023), Eagle Pharmaceuticals's total revenue was $64.65M, a decrease of -12.80% from the same quarter last year. In Q2, Eagle Pharmaceuticals's net income was $5.16M. See Eagle Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 316.61M$ 171.55M$ 187.80M$ 195.89M$ 213.31M
Gross Profit
$ 221.67M$ 129.37M$ 142.34M$ 135.00M$ 151.40M
Operating Expenses
$ 140.71M$ 126.60M$ 109.38M$ 113.18M$ 104.93M
Depreciation and Amortization
$ 12.02M$ 4.81M$ 4.77M$ 4.65M$ 3.67M
EBITDA
$ 77.50M$ 2.77M$ 30.02M$ 28.18M$ 40.44M
Operating Income
$ 80.96M$ -2.91M$ 25.25M$ 21.82M$ 36.62M
Other Income/Expenses
$ -19.53M$ -7.32M$ -10.28M$ 183.00K$ -2.58M
Pretax Income
$ 61.43M$ -4.55M$ 22.68M$ 22.00M$ 34.04M
Net Income
$ 35.64M$ -8.63M$ 11.99M$ 14.31M$ 31.90M
Per Share Metrics
Basic EPS
$ 2.76$ -0.66$ 0.89$ 1.04$ 2.16
Diluted EPS
$ 2.73$ -0.66$ 0.87$ 1.01$ 2.09
Weighted Average Shares Outstanding
12.93M 13.05M 13.48M 13.75M 14.77M
Weighted Average Shares Outstanding (Diluted)
13.07M 13.05M 13.77M 14.14M 15.28M
Currency in USD

Eagle Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis